Benutzer-Werkzeuge

Webseiten-Werkzeuge


centaurium_erythraea_rafn

Unterschiede

Hier werden die Unterschiede zwischen zwei Versionen angezeigt.

Link zu dieser Vergleichsansicht

Beide Seiten der vorigen Revision Vorhergehende Überarbeitung
Nächste Überarbeitung
Vorhergehende Überarbeitung
centaurium_erythraea_rafn [2015/03/12 10:27]
andreas
centaurium_erythraea_rafn [2016/05/07 10:02] (aktuell)
andreas
Zeile 4: Zeile 4:
 Annual or biennial herb, up to 50cm high, native to Eurasia, Central Asia, North Africa, naturalized in North America; leaves basal, oblong (first year); flowers wheel-shaped, pink (second year). Annual or biennial herb, up to 50cm high, native to Eurasia, Central Asia, North Africa, naturalized in North America; leaves basal, oblong (first year); flowers wheel-shaped, pink (second year).
  
-The dried aerial parts of C.erythraea are difficult to distinguish from other Centaurium species. They are used as bitter tonic to increase gastric juice production, to treat dyspeptic disorders and loss of appetite. The flowers have better bitterness values (6000-12000) than leaves (1300-3800) and stems (600-1200), so a high content of flowers is preferred. Centapicrin and desacetylcentapicrin, located exclusively in the ovary, are minor components but own the greatest bitterness values.\\ +The dried aerial parts of C.erythraea are difficult to distinguish from other Centaurium species. They are used as bitter tonic to increase gastric juice production, to treat dyspeptic disorders and loss of appetite. The flowers have better bitterness values (6000-12000) than leaves (1300-3800) and stems (600-1200), so a high content of flowers is preferred. The secoiridoid glucosides centapicrin and desacetylcentapicrin, located nearly exclusively in the ovary, are minor components but own the greatest bitterness values.\\ 
-[Kommentar zum DAB10, 1993] +[Kommentar zum DAB10, 1993] \\ 
 +[Hagers Handbuch der Pharmazeutischen Praxis, Springer 2010] 
 + 
 +{{:swertiamarin.jpg|swertiamarin}} swertiamarin
  
 Swertiamarin and sweroside, isolated from the aerial parts of Centaurium erythraea, "... inhibited the growth of Bacillus cereus, Bacillus subtilis, Citrobacter freundiiand Escherichia coli. While swertiamarin was also active against Proteus mirabilis and Serratia marcescens, sweroside inhibited the growth of Staphylococcus epidermidis." \\ Swertiamarin and sweroside, isolated from the aerial parts of Centaurium erythraea, "... inhibited the growth of Bacillus cereus, Bacillus subtilis, Citrobacter freundiiand Escherichia coli. While swertiamarin was also active against Proteus mirabilis and Serratia marcescens, sweroside inhibited the growth of Staphylococcus epidermidis." \\
Zeile 11: Zeile 14:
  
 "A bitter tonic to treat digestive disturbances, chronis dyspepsia, and lack of appetite. Traditionally thought to be helpful to treat fever and gastrointestinal, liver, bile, bladder and urological complaints. Externally used for wound treatment... \\ "A bitter tonic to treat digestive disturbances, chronis dyspepsia, and lack of appetite. Traditionally thought to be helpful to treat fever and gastrointestinal, liver, bile, bladder and urological complaints. Externally used for wound treatment... \\
-The plant contains bitter iridoid glycosides, so-called secoiridoids - mainly swertiamarin but also gentiopicrin, deacetylcentapicrin ans sweroside." \\+The plant contains bitter iridoid glycosides, so-called secoiridoids - mainly swertiamarin but also gentiopicrin, deacetylcentapicrin and sweroside." \\
 [Medicinal Plants of the World. Ben-Erik Van Wyk and Michael Wink, Pretoria 2004, 89] [Medicinal Plants of the World. Ben-Erik Van Wyk and Michael Wink, Pretoria 2004, 89]
 +
 +"The use of Centaurium erythraea Rafn has a long tradition in Europe, mainly in mild dyspeptic/ gastrointestinal disorders and in temporary loss of appetite... The medicinal use has been documented continuously in well-known handbooks... The pharmacological activity is attributed to the whole extract; however emphasis is put on the group of secoiridoid glycosides (‘bitters’) with main components swertiamarin, gentiopicroside, centapicrin and sweroside. Also xanthones, phenolic acids and other ingredients may contribute
 +to the pharmacological activity of Centaurii herba... There are no clinical safety data for extracts of Centaurii herba. In the documentation of the traditional medicinal use within the Community, no serious adverse effects have been reported." \\
 +[Assessment report on Centaurium erythraea Rafn s. L. including C. majus (H. et L.) Zeltner and C. suffruticosum (griseb.) Ronn., herba, for the development of a community herbal monograph, 2009] \\
 +[[http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2009/12/WC500018163.pdf]]
  
 The methanolic extract (ultrasonic maceration, freeze-dried, 'CE') of C.erythraea contained flavonoides, iridoids and xanthones. \\ The methanolic extract (ultrasonic maceration, freeze-dried, 'CE') of C.erythraea contained flavonoides, iridoids and xanthones. \\
-"The short-term (12 days) treatment of the STZ-diabetic rats with CE-extracts resulted in a 74% reduction of the produced hyperglycemia, which is only 6% less than the reduction caused by glibeclamide (GLB, positive control). The CE-extract had a significant impact on the hepatic carbohydrate metabolism enhancing the direct synthesis of glycogen, normalizing phosphorylase a activity and reducing the activity of glucose-6-phosphatase, which further causes reduction in production of blood glucose level. The long-term (45 days) treatment showed that the HbA1c in CE-treated group of animals was even lower than in the GLB-treated groups. The antilipidemic assessment of the CE-extract revealed decrease of total cholesterol, triglycerides, HDL and LDL level in the blood of the normal and STZ-hyperglycemic rats." \\+"The short-term (12 days) treatment of the STZ-diabetic rats with CE-extracts resulted in a 74% reduction of the produced hyperglycemia, which is only 6% less than the reduction caused by glibenclamide (GLB, positive control). The CE-extract had a significant impact on the hepatic carbohydrate metabolism enhancing the direct synthesis of glycogen, normalizing phosphorylase a activity and reducing the activity of glucose-6-phosphatase, which further causes reduction in production of blood glucose level. The long-term (45 days) treatment showed that the HbA1c in CE-treated group of animals was even lower than in the GLB-treated groups. The antilipidemic assessment of the CE-extract revealed decrease of total cholesterol, triglycerides, HDL and LDL level in the blood of the normal and STZ-hyperglycemic rats." \\
 [Chemical characterization of Centaurium erythrea L. and its effects on carbohydrate and lipid metabolism in experimental diabetes., Stefkov, G., Miova, B., Dinevska-Kjovkarovska, S., Stanoeva, J.P., Stefova, M., Petrusevska, G., Kulevanova, S., Journal of ethnopharmacology, Vol.152(1), 2014, 71-77]  [Chemical characterization of Centaurium erythrea L. and its effects on carbohydrate and lipid metabolism in experimental diabetes., Stefkov, G., Miova, B., Dinevska-Kjovkarovska, S., Stanoeva, J.P., Stefova, M., Petrusevska, G., Kulevanova, S., Journal of ethnopharmacology, Vol.152(1), 2014, 71-77] 
  
Zeile 26: Zeile 34:
 Fuchs, L., New Kreüterbuch, t.217 (1543) \\ Fuchs, L., New Kreüterbuch, t.217 (1543) \\
 [[http://plantgenera.org/species.php?id_species=220560]] [[http://plantgenera.org/species.php?id_species=220560]]
 +
 +{{:centaurium_erythraea.bgm.jpg?800}} \\
 +Centaurium erythraea, [[https://creativecommons.org/licenses/by-sa/3.0/de/|CC BY-SA 3.0]], Author: Andreas Kraska
centaurium_erythraea_rafn.1426152475.txt.gz · Zuletzt geändert: 2015/03/12 10:27 von andreas